These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Photoselective vaporization of the prostate: initial experience with a new 80 W KTP laser for the treatment of benign prostatic hyperplasia. Hai MA; Malek RS J Endourol; 2003 Mar; 17(2):93-6. PubMed ID: 12689402 [TBL] [Abstract][Full Text] [Related]
23. Feasibility of holmium laser enucleation of the prostate (HoLEP) for recurrent/residual benign prostatic hyperplasia (BPH). Elshal AM; Elmansy HM; Elhilali MM BJU Int; 2012 Dec; 110(11 Pt C):E845-50. PubMed ID: 22702908 [TBL] [Abstract][Full Text] [Related]
24. Photoselective vaporization of the enlarged prostate with KTP laser: long-term results in 240 patients. Sarica K; Alkan E; Lüleci H; Taşci AI J Endourol; 2005 Dec; 19(10):1199-202. PubMed ID: 16359215 [TBL] [Abstract][Full Text] [Related]
25. Clinical impact of tamsulosin on generic and symptom-specific quality of life for benign prostatic hyperplasia patients: using international prostate symptom score and Rand Medical Outcomes Study 36-item Health Survey. Suzuki H; Yano M; Awa Y; Nakatsu H; Egoshi K; Mikami K; Ota S; Okano T; Hamano S; Ohki T; Furuya Y; Ichikawa T Int J Urol; 2006 Sep; 13(9):1202-6. PubMed ID: 16984553 [TBL] [Abstract][Full Text] [Related]
26. Laser prostatectomy: two and a half years' experience with aggressive multifocal therapy. Kollmorgen TA; Malek RS; Barrett DM Urology; 1996 Aug; 48(2):217-22. PubMed ID: 8753732 [TBL] [Abstract][Full Text] [Related]
27. Impact of prostate-specific antigen level and prostate volume as predictors of efficacy in photoselective vaporization prostatectomy: analysis and results of an ongoing prospective multicentre study at 3 years. Te AE; Malloy TR; Stein BS; Ulchaker JC; Nseyo UO; Hai MA BJU Int; 2006 Jun; 97(6):1229-33. PubMed ID: 16686717 [TBL] [Abstract][Full Text] [Related]
28. Efficacy of high-energy transurethral microwave thermotherapy in alleviating medically refractory urinary retention due to benign prostatic hyperplasia. Kellner DS; Armenakas NA; Brodherson M; Heyman J; Fracchia JA Urology; 2004 Oct; 64(4):703-6. PubMed ID: 15491705 [TBL] [Abstract][Full Text] [Related]
29. Interstitial laser coagulation for management of benign prostatic hyperplasia: long-term follow-up. Terada N; Arai Y; Okubo K; Ichioka K; Matsui Y; Yoshimura K; Terai A Int J Urol; 2004 Nov; 11(11):978-82. PubMed ID: 15509201 [TBL] [Abstract][Full Text] [Related]
30. Transurethral microwave thermotherapy for treatment of benign prostatic hyperplasia: a preliminary assessment of the Prostalund feedback treatment machine. Kehinde EO; Abul F Med Princ Pract; 2005; 14(4):272-6. PubMed ID: 15961940 [TBL] [Abstract][Full Text] [Related]
32. Usage of GreenLight HPS 180-W laser vaporisation for treatment of benign prostatic hyperplasia. Jovanović M; Džamić Z; Aćimović M; Kajmaković B; Pejčić T Acta Chir Iugosl; 2014; 61(1):57-61. PubMed ID: 25782227 [TBL] [Abstract][Full Text] [Related]
33. Interstitial laser coagulation versus transurethral prostate resection for treating benign prostatic obstruction: a randomized trial with 2-year follow-up. Kursh ED; Concepcion R; Chan S; Hudson P; Ratner M; Eyre R Urology; 2003 Mar; 61(3):573-8. PubMed ID: 12639650 [TBL] [Abstract][Full Text] [Related]
34. Low-power laser radiation for the treatment of benign prostatic hyperplasia: initial clinical experience. Orihuela E; Motamedi M; Pow-Sang M; Lahaye M; Warren M J Endourol; 1994 Aug; 8(4):301-4. PubMed ID: 7526931 [TBL] [Abstract][Full Text] [Related]
35. Bipolar transurethral enucleation and resection of the prostate versus bipolar resection of the prostate for prostates larger than 60gr: A retrospective study at a single academic tertiary care center. Wei Y; Xu N; Chen SH; Li XD; Zheng QS; Lin YZ; Xue XY Int Braz J Urol; 2016; 42(4):747-56. PubMed ID: 27564286 [TBL] [Abstract][Full Text] [Related]
36. Transurethral evaporation of prostate (TUEP) with Nd:YAG laser using a contact free beam technique: results in 61 patients with benign prostatic hyperplasia. Narayan P; Fournier G; Indudhara R; Leidich R; Shinohara K; Ingerman A Urology; 1994 Jun; 43(6):813-20. PubMed ID: 7515205 [TBL] [Abstract][Full Text] [Related]
37. [Photoselective vaporization of the prostate (PVP) using 80 watt high power potassium-titanyl-phosphate (KTP) laser for benign prostatic hyperplasia: the first fifty-seven patients in Japan]. Kuromatsu I; Imamura T; Sugimura Y Nihon Hinyokika Gakkai Zasshi; 2006 Nov; 97(7):815-22. PubMed ID: 17154023 [TBL] [Abstract][Full Text] [Related]
38. Transurethral ethanol ablation of the prostate for symptomatic benign prostatic hyperplasia: long-term follow-up. El-Husseiny T; Buchholz N J Endourol; 2011 Mar; 25(3):477-80. PubMed ID: 21355774 [TBL] [Abstract][Full Text] [Related]
39. Minimally invasive treatment of BPH with interstitial diode laser coagulation. Diana M; Schettini M; Gallucci M Arch Ital Urol Androl; 1999 Feb; 71(1):1-5. PubMed ID: 10193016 [TBL] [Abstract][Full Text] [Related]
40. High power diode laser vaporization of the prostate: preliminary results for benign prostatic hyperplasia. Erol A; Cam K; Tekin A; Memik O; Coban S; Ozer Y J Urol; 2009 Sep; 182(3):1078-82. PubMed ID: 19616811 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]